The Rochester Protocol for Living Donor Liver Transplantation of Unresectable Colorectal Liver Metastasis: A 5-Year Report on Selection, Approval, and Outcomes

Living donor liver transplantation (LDLT) is a treatment option for select patients with unresectable colorectal liver metastasis. We describe our center’s experience of patient selection, insurance approval, and outcomes after LDLT after first referral in March 2019. Of the 206 evaluated patients,...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of transplantation
Main Authors:	Byrne, Matthew M., Chávez-Villa, Mariana, Ruffolo, Luis I., Loria, Anthony, Endo, Yutaka, Niewiemski, Amber, Jimenez-Soto, Cristina, Melaragno, Jennifer I., Ramaraju, Gopal A., Farooq, Priya D., Dunne, Richard F., Pineda-Solis, Karen, Nair, Amit, Orloff, Mark, Tomiyama, Koji, Hernandez-Alejandro, Roberto
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 25-09-2024
Subjects:	colorectal liver metastasis insurance approval living donor liver transplant selection criteria surgical innovation transplant oncology LDLT OS surgical innovation LT transplant oncology insurance approval colorectal liver metastasis CRC uCRLM SECA selection criteria living donor liver transplant CEA RFS Transplant oncology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!